Nippon Kayaku Co., Ltd.

Equities

4272

JP3694400007

Diversified Chemicals

Market Closed - Japan Exchange 02:00:00 2024-05-31 am EDT 5-day change 1st Jan Change
1,278 JPY +1.83% Intraday chart for Nippon Kayaku Co., Ltd. +1.47% -5.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nippon Kayaku's Fiscal-Year Attributable Profit Slumps 73% on Asset Impairment MT
Japanese Shares End Week in Red as China Data Disappoint; Toyo Tire Down Despite Robust Earnings MT
Nippon Kayaku Board Greenlights Up to 3 Billion Yen Share Buyback MT
Nippon Kayaku Co., Ltd. Provides End of Second Quarter and End of Year Dividend Guidance for the Fiscal Year Ending March 31, 2025 CI
Nippon Kayaku Co., Ltd. Announces Year End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024 CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2025 CI
Nippon Kayaku Co., Ltd. announces an Equity Buyback for 2,800,000 shares, representing 1.69% for ¥3,000 million. CI
Nippon Kayaku Co., Ltd. authorizes a Buyback Plan. CI
Nippon Kayaku to Book Extraordinary Loss of 2.56 Billion Yen in Fiscal 2024 MT
Nippon Kayaku Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Ending March 31, 2024 CI
Nippon Kayaku's Nine-Month Attributable Profit, Net Sales Slump MT
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Ending March 31, 2024 CI
Nippon Kayaku Co., Ltd. Provides Dividend Guidance for the Fiscal Ending March 31, 2024 CI
BioCheetah Pte. Ltd. Announces Exclusive Licensing and Commercialization Agreement with Nippon Kayaku Co., Ltd. for VECanDx in Japan CI
Nippon Kayaku Co., Ltd. Announces Dividend for the Second Quarter of the Year Ending March 31, 2024, Payable on December 1, 2023 CI
Nippon Kayaku Co., Ltd. and AnHeart Therapeutics Inc. Enter into Licensing Agreement CI
Nippon Kayaku Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Nippon Kayaku Co., Ltd. Revises Consolidated Earnings Guidance for the Six Months Ended September 30, 2023 CI
Adlai Nortye Ltd. announced that it has received $40 million in funding from Nippon Kayaku Co., Ltd. CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending March 31, 2024 CI
Nippon Kayaku Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Nippon Kayaku Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024 CI
Nippon Kayaku Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Ending March 31, 2024 CI
Nippon Kayaku Co., Ltd. Declares Dividend for the Year Ended March 31 2023, Payable on June 29, 2023 CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending March 31, 2024 CI
Chart Nippon Kayaku Co., Ltd.
More charts
NIPPON KAYAKU CO., LTD. is primarily engaged in the manufacture and sale of functional chemical products. The Company has three business segments. The Functional Chemical segment manufactures and sells functional materials, such as epoxy resin, ultraviolet curable resin and high-performance chemicals; pigment materials, including functional dyes, pigment for inkjet printers and others; catalysts, such as catalysts for acrylic and methacrylic acid manufacturing, as well as coloring materials, such as dyes and special coloring materials for nonfibrous products, among others. The Pharmaceutical segment supplies pharmaceutical products, medical intermediates and diagnostic medicines, among others. The Safety Systems segment provides inflators for airbags and micro gas generators for seatbelt pretensioners. The Company is also engaged in the manufacture and sale of agricultural chemicals.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 4272 Stock
  4. News Nippon Kayaku Co., Ltd.
  5. Nippon Kayaku Board Greenlights Up to 3 Billion Yen Share Buyback